Welcome to Sopharma AD A Prominent Name in Public Healthcare!
Back to Sopharma Home page Contact us  
Welcome to www.sopharma.com
16 Iliensko Chausee St.
Sofia, Bulgaria 1220
 


Cardiovascular drugs

Antistenocardin
Atenolol
Captopril
Chlophadon
Chlophasolin
Corazol
Furanthril
Isodinit
Monisid
Naniprus
Pharmacynon
Prenylamin
Sydnopharm
Verapamil


Phytochemical Products from Plant origin

. Tribestan
Phytin
Carsil
Nivalin
Tabex


Pharmaceutical substances

. Silymarin
. Cytisine
. Esculin
. Galantamine bromide
. Glaucin hydrobromide
. Phytin
. Peflavit
. Tribulus terrestris
. Valerian dry extract


Pharmaceutical products

Fifteen categories
 

 

 

 

VASOTON

 
 
StockNo Product description Status
EB0280-424-24 VASOTON AMPOULE 60 MG/1 ML (6%)
EB0280-424-39 VASOTON VIAL 10 ML 10% SOLUTION
 
COMPOSITION:
Synephrin tartrate 60 mg/1 ml in one ampoule and
10% - 10 ml solution

ACTION:
Adrenomimetic agent with vasoconstrictive effect. It has an excitatory action mainly on alpha - receptors which is the reason for its analeptic effect. It is characterized by moderate pressor activity, with a moderate duration of action. The phasic character of its action is not well manifested, as in the case of epinephrine but it has a longer effect. The drug stimulates the cardiac function. It is with a low toxicity and is well tolerated.

INDICATIONS:
Peripheral vascular failure - collapse and various hypotonic states, e.g. infectious diseases (flu, pneumonia, etc.), and during the convalescense period after them; prior to and after surgical operations; bronchial asthma; in obstetric practice.
The drug is usually administered in the lighter cases of the conditions described.

CONTRAINDICATIONS:
Hypertonic disease, manifested atherosclerosis, liability to vascular spasms, grave organic cardiac diseases, hyperthyroidism, diabetes (except in the case of vital indications).

SIDE EFFECTS:
Blood pressure can be elevated three times after overdosage and a prolonged administration; palpitation, arrhythmia (rarely), perspiration, dizziness, difficult urination, nervous excitation, insomnia.

DRUG INTERACTIONS:
Severe hypertensive reactions and arrhythmias are likely to occur after simultaneous administration with other sympathomimetic agents and antidepressants.

DOSAGE AND ADMINISTRATION:
Adults are given orally 15-30 drops, 30 min before meals.
Children: from 3 months to 1 year - 5-10 drops; from 1 to 4 years - 10-15 drops; from 4 to 10 years - 15-20 drops; doses can be given 2-3 times daily.
It is injected in acute cases: subcutaneously, intramuscularly or intravenously (slowly!). The injections can be repeated every 1-2 h until normal blood pressure values are attained. As long-lasting intravenous drip infusion - 5 to 10 ampoules = 0.3-0.6 Vasoton per liter infusion fluid for 4 to 8 h.

MEDICINAL FORM AND PACKAGE:
Packages with 10 and 50 ampoules of 60 mg/1 ml (6 %).
Solution - 10 % in vials of 10 ml.

STORAGE:
At moderate temperature (15-30° C).

EXPIRY:
2 (two) years.

 

 

Central nervous system Bellergamin Centrophenoxine Chlorazin Cinnarizine Diazepam Haloperidol Lydol Morphine Natrium bromatum Phenobarbital Piracetam Tempalgin Tilidine adrenaline Atropine Lidocaine Nivabex Nivalin Pymadin Tabex Cardiovascular Antistenocardin Atenolol Captopril Chlophadon Chlophazolin Diltiazem Furosemide Isocor Naniprus Pentofyllin Pharmacynon Vasopren Digestive system Ranitidine Sopral Pulmonary system Bromhexin Broncholytin Codterpin Dimex Glauvent Salbutamol Sophafyllin Amidophen Analgin Feloran Indomethacin Paracetamol Piroxicam Buscolysin Papaverine Antibiotic Amikacin Chlorquinaldol Ethambutol Gentamicin Rimicid Progesterone Testosterone Allergosan Ketotifen Vitamins, Minerals & Enzymes Calcium Phospho C Deavit Deflamol Peflavit C Vitamins Furotalgin Pilocarpine Rhinolex Sulfacetamide Mycodermin Revulsan Univertan Zinc ointment Phytin Tribestan Antistrumin Bisacodyl Calcium gluconicum Glibenclamide Methilprednisolone Natrium citricum Natrim chloratum Phlebescin

© 1999-2001 Sopharma USA Corporation. All rights reserved.
Copyright, Trademark, Disclaimer and Privacy statement.

A service of Bulgarian Pharmaceutical Group Ltd.

EB0280 01/28/2001